Sign In
Buy VERU
$2.25
-0.100 (-4.26%)
At Close: Jun 03, 2026
2 Top Healthcare Stocks Defying the Bear Market
01:45pm, Sunday, 09'th Oct 2022 The Motley Fool
Both companies have revenue rolling in today, and they both expect loads more in the near term.
2 Top Healthcare Stocks Defying the Bear Market
09:45am, Sunday, 09'th Oct 2022
Both companies have revenue rolling in today, and they both expect loads more in the near term.
Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
08:30pm, Tuesday, 04'th Oct 2022 GlobeNewswire Inc.
MIAMI, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for th
7 Momentum Stocks to Buy Now for Extraordinary Gains
06:45am, Monday, 26'th Sep 2022
Before jumping directly into momentum stocks worth buying now, it's important to understand what momentum trading is. As the name implies, momentum trading relies on reacting to the current movement o
Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday
08:04am, Thursday, 22'nd Sep 2022 Benzinga
Gainers
Stabilis Solutions, Inc. (NASDAQ: SLNG) shares climbed 71.3% to close at $8.84 after the company announced it has received authorization from the U.S. Department of Energy to export domestic
Why Adamis Pharmaceuticals Is Trading Lower By Around 44%, Here Are 46 Stocks Moving In Wednesday's Mid-Day Session
04:40pm, Wednesday, 21'st Sep 2022 Benzinga
Gainers
Stabilis Solutions, Inc. (NASDAQ: SLNG) shares jumped 108% to $10.73 after the company announced it has received authorization from the U.S. Department of Energy to export domestically produ
Veru to Participate in the Cantor Oncology, Hematology & HemeOnc Conference on September 28th, 2022
12:30pm, Wednesday, 21'st Sep 2022 GlobeNewswire Inc.
MIAMI, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for t
Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday
07:16am, Tuesday, 20'th Sep 2022 Benzinga
Gainers
Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) shares jumped 54.6% to settle at $7.05 on Monday.
Purple Innovation, Inc. (NASDAQ: PRPL) shares surged 39.4% to close at $3.89 after the company
Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday's Mid-Day Session
04:29pm, Monday, 19'th Sep 2022 Benzinga
Gainers
MicroCloud Hologram Inc. (NASDAQ: HOLO) shares jumped 134.6% to $19.74.
BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) gained 112.8% to $8.83 after the company announced it has signed a sha
--Advisory Committee Meeting with Same Agenda Has Been Rescheduled to November 09, 2022-- --Advisory Committee Meeting with Same Agenda Has Been Rescheduled to November 09, 2022--
Kroger, DocuSign And Other Big Gainers From Friday
09:14am, Monday, 12'th Sep 2022 Benzinga
U.S. stocks closed higher with the Nasdaq Composite surging 250 points on Friday. Here is the list of some big stocks recording gains in the previous session.
Veru Inc. (NASDAQ: VERU) rose 21.9% to s
Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday
07:23am, Monday, 12'th Sep 2022 Benzinga
Gainers
Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in
Veru Inc.: A Very Complicated Tale
12:49pm, Thursday, 08'th Sep 2022
Today, we put Veru Inc. in the spotlight for the first time. The stock fell over 20% trading Wednesday after the FDA stated it would require an AdComm Panel for the company's COVID-19 therapy sabizabu
Why IMARA Jumped Around 75%; Here Are 54 Biggest Movers From Yesterday
09:26am, Thursday, 08'th Sep 2022 Benzinga
Gainers
IMARA Inc. (NASDAQ: IMRA) jumped 74.8% to settle at $2.01 on Wednesday after the company announced it entered into an asset purchase agreement with Cardurion Pharmaceuticals to sell tovinontr
Veru Announces Date for FDA Advisory Committee Meeting to Review Emergency Use Authorization for Sabizabulin for Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome
05:45pm, Wednesday, 07'th Sep 2022 GlobeNewswire Inc.
—Advisory Committee Meeting Scheduled for October 06, 2022— —Advisory Committee Meeting Scheduled for October 06, 2022—
